Description
Tesamorelin is a synthetic GHRH analogue — active compound in FDA-approved Egrifta®, making it one of the most clinically validated peptides available.
Research Applications
- Visceral adiposity and lipodystrophy research
- Growth hormone axis studies
- Metabolic health research
- Body composition research
Product Specifications
- Purity: 99%+ (HPLC verified)
- Form: Lyophilized powder
- Storage: 2-8°C; stable 24 months frozen
For research and laboratory use only. Not intended for human or animal consumption.



Reviews
There are no reviews yet.